跳转至内容
Merck
所有图片(1)

Key Documents

8.52079

Sigma-Aldrich

Fmoc-Asp-ODmab

Novabiochem®

别名:

Fmoc-Asp-ODmab, N-α-Fmoc-L-aspartic acid α-4-{N-[1-(4,4-dimethyl-2,6-dioxocyclohexylidene)-3-methylbutyl]-amino} benzyl ester

登录查看公司和协议定价


About This Item

经验公式(希尔记法):
C39H42N2O8
分子量:
666.76
分類程式碼代碼:
12352209
NACRES:
NA.22

品質等級

產品線

Novabiochem®

化驗

≥95.0% (HPLC)
≥97% (TLC)

形狀

powder

反應適用性

reaction type: Fmoc solid-phase peptide synthesis

製造商/商標名

Novabiochem®

應用

peptide synthesis

官能基

carboxylic acid

儲存溫度

15-25°C

一般說明

Quasi-orthogonally-protected Asp derivative.The Dmab group can be removed selectively in the presence of tBu-based protecting groups by treatment with 2% hydrazine in DMF [1], making this derivative an extremely useful tool for the preparation of cyclic peptides by Fmoc SPPS or for library synthesis. Occasionally sluggish cleavage of the aminobenzyl moiety is observed [2,3]. In these instances, washing the support with 20% DIPEA in DMF/water (9:1) [2] or HCl in dioxane [4] has been found to be efficacious. For the on-resin synthesis of side-chain to side-chain lactam bridged peptides, the combination of Lys(ivDde) and Asp(ODmab) is particularly advantageous since both side-chains can be simultaneously unmasked in a single step.To avoid aspartimide formation, it is advisable to employ an Hmb- or Dmb-protected derivative for introduction of the preceding residue.For applications of this derivative in the synthesis of cyclic peptides, see references [5 - 7].

Associated Protocols and Technical Articles
Cleavage and Deprotection Protocols for Fmoc SPPS

Literature references

[1] W. C. Chan, et al. (1995) J. Chem. Soc., Chem. Commun., 2209.
[2] S. Künzel, et al. Poster 17 presented at Solid Phase Synthesis & Combinatorial Libraries, Southampton, September 2001.
[3] K. F. Medzihradszky, et al. (2002) Lett. Pept. Sci., 8, 1.
[4] Albericio, et al.Poster 44 presented at American Peptide Symposium, San Diego 2005..
[5] M. Cudic, et al. in ′Peptides 2000, Proc. 26th European Peptide Symposium′, J. Martinez & J.-A. Fehrentz (Eds), Paris, Editions EDK, 2001, pp. 203.
[6] M. Cudic, et al. (2000) Tetrahedron Lett., 41, 4527.
[7] J. P. Malkinson, et al. (2003) Org. Lett., 5, 5051.

聯結

Replaces: 04-12-1176

分析報告

Color (visual): white to slight yellow to beige
Appearance of substance (visual): powder
Identity (IR): passes test
Enantiomeric purity: ≥ 99.0 % (a/a)
Purity (TLC(157A)): ≥ 97 %
Purity (TLC(CMA2)): ≥ 97 %
Assay (HPLC, area%): ≥ 95.0 % (a/a)
Solubility (1 mmole in 2 ml DMF): clearly soluble
Water (K. F.): ≤ 1.0 %

To see the solvent systems used for TLC of Novabiochem® products please click here.

法律資訊

Novabiochem is a registered trademark of Merck KGaA, Darmstadt, Germany

儲存類別代碼

11 - Combustible Solids

水污染物質分類(WGK)

WGK 2

閃點(°F)

Not applicable

閃點(°C)

Not applicable


分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ (Lot或Batch)字后找到。

已有该产品?

在文件库中查找您最近购买产品的文档。

访问文档库

商品

Novabiochem® offers orthogonally protected amino acids for peptide synthesis, including cyclic and branched peptides.

Novabiochem® offers orthogonally protected amino acids for peptide synthesis, including cyclic and branched peptides.

Novabiochem® offers orthogonally protected amino acids for peptide synthesis, including cyclic and branched peptides.

Novabiochem® offers orthogonally protected amino acids for peptide synthesis, including cyclic and branched peptides.

我们的科学家团队拥有各种研究领域经验,包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门